Risk stratification for desensitization of patients with carboplatin hypersensitivity: Clinical presentation and management

The timing of carboplatin ST in relation to initial HSR is vital for risk stratification and subsequent desensitization. Initial ST− patients with a remote history of HSR are at high risk for conversion to ST+ and can develop more severe HSR.